Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: J Allergy Clin Immunol. 2017 Jun 1;141(3):1085–1095. doi: 10.1016/j.jaci.2017.02.047

Table 5.

Correlations between baseline-to-follow-up changes in asthma status measures and changes in A-IQOLS and QOLS scores, with estimates of shared variance, n=147.

Change in
Characteristic
Association with change in
A-IQOLS Score
Association with change in
QOLS Score
Clinical Characteristics Mean ± SD r* p R2 r* p R2
FEV1 Percent Predicted, pre-bronchodilator† −0.74 ± 8.06 0.10 0.22 0.01 −0.08 0.32 0.01
ACT 0.79 ± 3.16 −0.40 <0.0001 0.16 −0.07 0.40 0.005
ASUI‡ 0.04 ± 0.15 −0.33 <0.0001 0.11 −0.02 0.77 0.001
Marks AQLQ −2.59 ± 7.02 0.52 <0.0001 0.27 −0.005 0.96 <0.01
Mini-AQLQ: Total Score 0.28 ± 0.78 −0.55 <0.0001 0.30 0.07 0.38 0.01
Mini-AQLQ: Symptom Score 0.36 ± 0.93 −0.45 <0.0001 0.20 0.06 0.49 0.003
PHQ-9 −1.03 ± 2.96 0.20 0.01 0.04 −0.16 0.053 0.03
No. exacerbations requiring OCS§ 0.01 ± 0.27 0.10‖ 0.24 0.01 0.01‖ 0.89 <0.01
No. asthma-related medical visits¶ 0.04 ± 0.49 0.11‖ 0.20 0.01 −0.07‖ 0.41 <0.01
A-IQOLS −0.10 ± 0.37 - - - −0.15 0.07 0.02
QOLS −0.10 ± 0.61

Abbreviations: A-IQOLS, Asthma Impact on Quality of Life Scale; QOLS, Flanagan Quality of Life Scale; FEV1, forced expiratory volume in one second; ACT, Asthma Control Test; ASUI, Asthma Symptom Utility Index; Marks AQLQ, Asthma Quality of Life Questionnaire; Mini-AQLQ, Juniper mini-Asthma Quality of Life Questionnaire, total score and symptom sub-scale; PHQ-9, Patient Health Questionnaire.

*

r=Pearson product-moment correlation

Sample size, n=146.

Sample size, n=146.

§

OCS (oral corticosteroid) prescription of at least 3 days for an asthma-related diagnosis code (asthma, ICD9 493.x; cough, ICD9 786.2; bronchitis, ICD9 490; upper respiratory infection, ICD(465.9; bronchospasm, ICD9 519.11; or wheezing, CD9 786.07) within 4 weeks preceding enrollment. Courses of OCS separated by >7 days were treated as separate exacerbations. See Asthma outcomes: Exacerbations. Fuhlbrigge, A., et al. J Allergy Clin Immunol, 2012:129(3);S34–S48.

Spearman Rank-Order Correlation.

Outpatient office visit or Urgent Care Clinic visit with asthma diagnosis code (ICD9 493.x) within 4 weeks preceding enrollment. Does not include hospital emergency department visits.